Clinical implication of PLR and PD-L1 in breast cancer patients

被引：0
|
作者：
Wang, S. [1 ]
Lu, Q. [1 ]
Qin, T. [1 ]
Xu, F. [1 ]
Zeng, Y. [2 ]
Xia, W. [1 ]
Zheng, Q. [1 ]
Lee, K. [1 ]
Zhang, K. [1 ]
Qin, G. [1 ]
Kong, M. T. [3 ]
Hong, R. [1 ]
Shi, Y. [1 ]
Yuan, Z. [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Med Oncol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Mem Hosp, Breast Canc, Guangzhou, Guangdong, Peoples R China
[3] Hosp Conde S Januario, Internal Med, Macau, Macau, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
基金：
中国国家自然科学基金;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
109P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical implication of platelet-lymphocyte ratio and PD-L1 in breast cancer patients
    Lu, Qianyi
    Qin, Tao
    Xu, Fei
    Zeng, Yinduo
    Xia, Wen
    Zheng, Qiufan
    Lee, Kaping
    Zhang, Kai
    Qin, Ge
    Kong, Man Tek
    Hong, Ruoxi
    Shi, Yanxia
    Yuan, Zhongyu
    Wang, Shusen
    [J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 659 - 667
  • [2] Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
    Kim, Yeorae
    Aiob, Ala
    Kim, Hyojin
    Suh, Dong Hoon
    Kim, Kidong
    Kim, Yong Beom
    No, Jae Hong
    [J]. BIOMEDICINES, 2023, 11 (10)
  • [3] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    [J]. BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [4] Regulation of PD-L1 in breast cancer
    Zerdes, Ioannis
    Tsesmetzis, Nikolaos
    Lovrot, John
    Rolny, Charlotte
    Bergh, Jonas C. S.
    Rassidakis, Georgios
    Foukakis, Theodoros
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
    Baojuan Han
    Lina Dong
    Jing Zhou
    Yan Yang
    Jiaxun Guo
    Qijia Xuan
    Kun Gao
    Zhenguo Xu
    Wanting Lei
    Jingxuan Wang
    Qingyuan Zhang
    [J]. Cancer Immunology, Immunotherapy, 2021, 70 : 2893 - 2909
  • [6] The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte
    Han, Baojuan
    Dong, Lina
    Zhou, Jing
    Yang, Yan
    Guo, Jiaxun
    Xuan, Qijia
    Gao, Kun
    Xu, Zhenguo
    Lei, Wanting
    Wang, Jingxuan
    Zhang, Qingyuan
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 2893 - 2909
  • [7] PD-L1 testing in breast cancer
    Horii, Rie
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1361 - S1361
  • [8] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar Vs
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 77A - 77A
  • [9] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    [J]. MODERN PATHOLOGY, 2016, 29 : 77A - 77A
  • [10] PD-L1 expression on circulating monocytes in patients with breast cancer
    Nagano, M.
    Saito, K.
    Kozuka, Y.
    Shibusawa, M.
    Imai, N.
    Noro, A.
    Kageyama, Y.
    Mizuno, T.
    Ogawa, T.
    Katayama, N.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345